AUS
NZ
UK
CA
USA
IND
Healthcare
How Is GlaxoSmithKline PLC (LSE:GSK) Advancing in the FTSE All Share Healthcare Sector?
July 28, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,GlaxoSmithKline PLC has entered into a development agreement involving multiple experimental medicines.,The collaboration introduces a dry-powder inhaler aimed at addressing inflammation and airway tightening.,The company is a constituent...
Is Smith & Nephew PLC (LSE:SN) Elevating FTSE 100 Surgical Innovation?
July 28, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,Smith & Nephew PLC operates in the medical technology and surgical equipment sector.,The company is listed among FTSE 100 entities, known for high market capitalisation in the UK.,Its focus spans orthopaedics, sports medicine, and wound ma...
Is PureTech Health (LSE:PRTC) Gaining Attention Following Public Shareholding Disclosure?
July 27, 2025 10:30 AM BST| By Team Kalkine MediaHighlights,PureTech Health operates in the biopharmaceutical sector with a focus on clinical-stage research.,Recent data shows the distribution of shares among institutional and public shareholders.,Shareholding transparency aligns with standard gove...
What Drove hVIVO (LSE:HVO) After Its H1 Update?
July 26, 2025 06:03 PM BST| By Team Kalkine MediaHighlights,hVIVO released its half-year trading update covering contract execution.,Revenue recognition aligned with pre-agreed delivery timelines.,Operational activity continued across current client agreements.,The clinical research sector took not...
_06_27_2025_01_29_51_988272.jpg)
Genflow Biosciences (LON:GENF) Advances Gene Therapy Projects Aimed at Tackling Aging
July 25, 2025 09:25 AM BST| By Team Kalkine MediaHighlights,Genflow Biosciences PLC (LON:GENF) prepares lead therapy GF-1002 for clinical trial authorisation,Collaborates with Exothera to meet quality manufacturing standards,Secures regional support from Belgium to boost longevity research pipeline...
Is Creo Medical Group (LSE:CREO) Advancing Its Role in the Healthcare Device Sector Amid Fresh Activity?
July 24, 2025 04:02 PM BST| By Team Kalkine MediaHighlights,Reported equity-related event involving Creo Medical Group.,The company focuses on energy-based medical device technologies.,Activity disclosed through regulatory reporting channels.,Creo Medical Group (LSE:CREO) operates in the healthcare...
Are Biotech and Exploration Companies Like (LSE:SCLP) Shaping Market Headlines Today?
July 22, 2025 10:50 AM BST| By Team Kalkine MediaHighlights,Scancell Holdings shares progress in its cancer immunotherapy programmes.,Clinical trial updates released by IXICO and hVIVO.,Thor Explorations and Oriole Resources report new exploration activity.,Scancell Holdings (LSE:SCLP), part of the...
Could Scancell’s Melanoma Trial Results Signal a New Chapter in Biotech Immunotherapy?
July 22, 2025 09:05 AM BST| By Team Kalkine MediaHighlights,Scancell reports Phase II data from Modi-1 trial in melanoma using peptide vaccine with checkpoint inhibitors.,Disease control and immune response observed across multiple patient groups.,Combination treatment with checkpoint inhibitors we...
Is Benchmark Holdings Restructuring Signaling a New Phase for Aquaculture Biotechnology?
July 21, 2025 12:28 PM BST| By Team Kalkine MediaHighlights,Benchmark Holdings announced executive leadership changes in preparation for delisting.,The company operates in the aquaculture biotechnology and life sciences sector.,Updates involve a shift to private ownership while retaining operationa...
Why Did Immupharma (LSE:IMM) Share Price Jump in the Latest Session?
July 21, 2025 10:50 AM BST| By Team Kalkine MediaHighlights,Immupharma recorded a sharp upward move during the most recent trading session.,The price change followed a company update regarding drug development progress.,Regulatory and operational developments were central to the latest announcement...
Why Is ImmuPharma (LSE:IMM) Gaining Attention in the Biotechnology Sector?
July 21, 2025 10:38 AM BST| By Team Kalkine MediaHighlights,ImmuPharma shares saw a sharp rise during recent trading.,The company is active in the biotechnology sector, focusing on autoimmune treatments.,Latest developments involve continued progress in its lead clinical candidate.,ImmuPharma (LSE:...
FTSE 100 Rises Despite Domestic Pressures as Haleon Stays Resilient
July 18, 2025 10:54 AM BST| By Team Kalkine MediaHighlights,FTSE 100 continues to climb, even as UK economic indicators remain under pressure,Haleon (LON:HLN), a major player in consumer healthcare, experiences steady growth,A globally diverse revenue base shields large UK-listed firms from local e...
FTSE 350 Market Sentiment Strengthens as GSK Reacts to Drug Trial and CFC Eyes London IPO
July 18, 2025 10:53 AM BST| By Team Kalkine MediaHighlights,GSK (GSK) reflects clinical trial response in the healthcare sector,CFC explores listing plans amid growing interest in London IPOs,UK tech infrastructure receives strong backing for AI expansion,The,FTSE 350,opened on a stronger footing,...
Can FTSE AIM 100's Craneware (LSE:CRW) Sustain Its Healthcare Software Positioning Amid Institutional Interest?
July 18, 2025 10:23 AM BST| By Team Kalkine MediaHighlights,Craneware operates within the healthcare software segment, offering value cycle management tools for hospitals.,Berenberg Bank initiated formal coverage of the company, reflecting continued institutional engagement.,The firm remains part o...
GSK Faces Regulatory Setback on Blenrep Combinations Amid FTSE100 Scrutiny
July 18, 2025 10:18 AM BST| By Team Kalkine MediaHighlights,FDA panel raises concerns over GSK’s Blenrep combinations,GSK maintains confidence in Blenrep’s potential,Global reviews for Blenrep continue despite US setback,GSK (LON:GSK), a major player in the pharmaceutical landscape and a constituen...
Is FTSE AIM 100's Craneware (LSE:CRW) Gaining Momentum in the Healthcare Tech Space?
July 18, 2025 09:07 AM BST| By Team Kalkine MediaHighlights,Craneware operates within the healthcare technology sector, delivering software solutions to hospitals and health systems.,The company’s recent updates have attracted renewed attention in the FTSE AIM 100 Index.,Shore Capital reaffirmed it...
Is Hutchmed (LSE:HCM) Gaining Ground on the FTSE AIM 100 Index?
July 18, 2025 08:44 AM BST| By Team Kalkine MediaHighlights,Hutchmed China saw a sharp rise in market capitalisation over a short period.,Company’s total value increased significantly based on changes in investor demand.,Market interest aligned with sector movements in the pharmaceutical and biotec...
GSK Faces Setback in FTSE 100 Live as US Panel Support for Blenrep Approval
July 18, 2025 07:50 AM BST| By Team Kalkine MediaHighlights,GSK’s oncology drug Blenrep did not secure backing from a US advisory panel.,The regulatory outcome may affect future revenue projections for the company.,Blenrep had previously been highlighted as a key component within GSK’s pharmaceutic...
Is FTSE AIM 100’s Advanced Medical Solutions (LSE:AMS) Gaining Market Attention?
July 17, 2025 09:25 AM BST| By Team Kalkine MediaHighlights,Berenberg Bank reiterated its previous stance on Advanced Medical Solutions Group.,Advanced Medical Solutions operates within the healthcare and medical device sector.,Updates reflect continued focus on surgical and woundcare technology de...
What’s Driving Renewed Interest in This UK Pharma Company?
July 16, 2025 12:48 PM BST| By Team Kalkine MediaHighlights,Shield Therapeutics operates within the pharmaceutical sector, focusing on specialty treatments.,The company recorded year-over-year revenue growth with an increase in prescriptions.,Leadership changes and U.S. commercial expansion efforts...
